Menu
Log in
Log in

ANCO - Education and Empowering the Northern California Cancer Community

Cancer Center Grand Rounds Series: Advances in Hematologic Malignancies and CAR T-Cell Therapy

  • 12/16/2020
  • 12:00 AM
Advances in Hematologic Malignancies and CAR T-Cell Therapy
Plus: A review of risks for opioid misuse and preventive strategies you can adopt in your practice.
Learning Objectives:
After completing this course, attendees will have improved their skills and strategies with regard to hematologic malignancies. Specifically, they will be able to:
  • Describe major advances made over the past two decades in allogeneic hematopoietic cell transplantation (HCT)
  • Summarize the impact of COVID-19 on adult HCT volumes
  • Discern diseases for which CAR T-cell therapy is approved and in development
  • Describe the most common side effects associated with CAR T-cell therapy.
  • Review the risks for opioid misuse by patients with cancer
  • Develop a strategy for managing opioids in their own clinical practices
    To secure your spot, please register in advance.
    The registration fee for CME credit is $45, but we are offering free registration to the first 20 registrants who use the promo code: First 20 Physician
    After registering online, you will receive a confirmation email with information on joining the webinar through Zoom.
    Individuals who wish to attend without the option for CME credit can register by emailing Kurstan.delRosario@ucsf.edu


Website:

https://conta.cc/2V0EJZR

Apply to Become a Member


4225 Solano Ave, #764
Napa, CA 94558
Phone (415) 472-3960

Association of Northern California Oncologists © 2025 | Privacy Policy | Disclaimer

Powered by Wild Apricot Membership Software